<VariationArchive RecordType="classified" VariationID="984497" VariationName="NC_000011.9:g.(5246957_5247806)_(5248302_?)del" VariationType="Deletion" Accession="VCV000984497" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-10-08" DateCreated="2020-11-14" MostRecentSubmission="2020-11-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="972531" VariationID="984497">
      <GeneList>
        <Gene Symbol="HBB" FullName="hemoglobin subunit beta" GeneID="3043" HGNC_ID="HGNC:4827" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5225464" stop="5227071" display_start="5225464" display_stop="5227071" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="5246695" stop="5248300" display_start="5246695" display_stop="5248300" Strand="-" />
          </Location>
          <OMIM>141900</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000011.9:g.(5246957_5247806)_(5248302_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p15.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" outerStart="5246957" innerStart="5247806" innerStop="5248302" display_start="5246957" display_stop="5248302" variantLength="497" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.(5246957_5247806)_(5248302_?)del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.(5246957_5247806)_(5248302_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000011.9:g.(5246957_5247806)_(5248302_?)del AND beta Thalassemia" Accession="RCV001264539" Version="1">
        <ClassifiedConditionList TraitSetID="4697">
          <ClassifiedCondition DB="MedGen" ID="C0005283">beta Thalassemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-10-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-10-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-11-14" MostRecentSubmission="2020-11-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1719807</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2456798</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2753736</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2920214</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32001505</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">6089938</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="4697" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="11970" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">beta Thalassemia</ElementValue>
                <XRef ID="Beta+Thalassemia/814" DB="Genetic Alliance" />
                <XRef ID="65959000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cooley's anemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Erythroblastic anemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mediterranean anemia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BTHAL</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Beta-thalassemia (ÃŸ-thalassemia) is characterized by reduced synthesis of the hemoglobin subunit beta (hemoglobin beta chain) that results in microcytic hypochromic anemia, an abnormal peripheral blood smear with nucleated red blood cells, and reduced amounts of hemoglobin A (HbA) on hemoglobin analysis. Individuals with thalassemia major have severe anemia and hepatosplenomegaly; they usually come to medical attention within the first two years of life. Without treatment, affected children have severe failure to thrive and shortened life expectancy. Treatment with a regular transfusion program and chelation therapy, aimed at reducing transfusion iron overload, allows for normal growth and development and may improve the overall prognosis. Individuals with thalassemia intermedia present later and have milder anemia that does not require regular treatment with blood transfusion. These individuals are at risk for iron overload secondary to increased intestinal absorption of iron as a result of ineffective erythropoiesis.</Attribute>
                <XRef ID="NBK1426" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520044" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556525" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501908" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521590" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260581" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501386" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501909" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515560" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529085" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000567333" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570317" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592286" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592333" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508856" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520115" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556526" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558937" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592332" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596318" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301599</ID>
                <ID Source="BookShelf">NBK1426</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACOG, 2021">
                <ID Source="PubMed">17197616</ID>
              </Citation>
              <XRef ID="848" DB="Orphanet" />
              <XRef ID="C0005283" DB="MedGen" />
              <XRef ID="MONDO:0019402" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2848735" SubmissionDate="2020-11-10" DateLastUpdated="2020-11-14" DateCreated="2020-11-14">
        <ClinVarSubmissionID localKey="NC_000011.9:g.(5246957_5247806)_(5248302_?)del|MedGen:C0005283" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001442744" DateUpdated="2020-11-14" DateCreated="2020-11-14" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1719807</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2920214</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2753736</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2456798</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">6089938</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32001505</ID>
          </Citation>
          <Comment>Variant summary: The variant identified by MLPA or other technology involves the deletion of the promoter region and exons 1-2 in the HBB gene. Although exact breakpoints of this deletion are not known, a presumed nomenclature of c.(?_-51)_(315+1_316-1)del has been designated for the purposes of this classification. This variant is expected to result in a large deletion in the HBB gene, a known mechanism of disease. The variant was absent in approximately 21000 control chromosomes (gnomAD structural variants database). This variant has been reported in the literature in multiple individuals affected with a mild form of Beta Thalassemia, typically presenting with high levels of HbA2 and HbF (examples- Padanilam_1984, Anand_1988, Thein_1989). In addition, the variant has been reported in compound heterozygosity with a HgbS mutation in multiple affected individuals (examples-Padanilam_1984, Waye_1991, Wang_2020). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.(5246957_5247806)_(5248302_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">beta Thalassemia</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0005283" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8492518</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2848735" TraitType="Disease" MappingType="Name" MappingValue="beta Thalassemia" MappingRef="Preferred">
        <MedGen CUI="C0005283" Name="beta Thalassemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

